Financial statements Bioniko
Balance sheet data of BIONIKO
Year
|
2020
|
2022
|
2023
|
2024
|
---|---|---|---|---|
Total assets | 87 338,75 | 25 789,21 | 12 578,24 | 9 300,93 |
A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 |
B. Current assets | 87 338,75 | 25 789,21 | 12 578,24 | 9 300,93 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 87 338,75 | 25 789,21 | 12 578,24 | 9 300,93 |
A. Equity | -2 672,03 | 6 345,50 | 11 402,17 | 932,30 |
B. Liabilities and provisions for liabilities | 90 010,78 | 19 443,71 | 1 176,07 | 8 368,63 |
I. Long-term liabilities | - | - | - | - |
II. Short-term liabilities | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.